550NewsAustralia’s Fashion powerhouse Lovisa deploys Infor WMS in record five months
Infor solution helps maximise operational flexibility, allowing an improved service offering for inventory in Lovisa’s store network throughout Europe SYDNEY, AUSTRALIA –...
- 417News
Prince Holding Group Welcomes SBIF Delegation & Discusses Strategic Collaborations
PHNOM PENH, CAMBODIA – Media OutReach – 16 June 2023 – Prince Holding Group (Prince Group), a leading business group in Cambodia,...
- 542News
UFC Fight Night: Holloway VS. The Korean Zombie in Singapore for Asia Prime Time Showdown in August
SINGAPORE – Media OutReach – 16 June 2023 – UFC®, the world’s premier Mixed Martial Arts (MMA) organization, returns to Singapore with...
- 459Wire Stories
Latest Data of InnoCare’s Orelabrutinib Presented at the 17th International Conference on Malignant Lymphoma (ICML)
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, today announced the latest clinical data of its Bruton Tyrosine Kinase...
- 476Wire Stories
Takeda and HUTCHMED Announce Publication of Phase 3 FRESCO-2 Results in The Lancet
− Publication shows FRESCO-2 demonstrated treatment with fruquintinib reduced the risk of death by 34% in previously treated metastatic colorectal cancer (0.66...
- 475News
Oriental wellness expert Ananchi introduces new Japanese bust care technology, launching a new wellness center in Central Hong Kong
HONG KONG SAR – Media OutReach – 16 June 2023 – Ananchi, a wellness boutique established in 2019 with a specialization in...
- 489Wire Stories
SEE Upcoming Event with the Asia Pacific Financial Community
Tokyo, Japan CHARLOTTE, N.C.–(BUSINESS WIRE)–SEE (NYSE: SEE) will participate in the following event. Ted Doheny, President and CEO, and members of his...
- 435Wire Stories
Takeda and HUTCHMED Announce Marketing Authorization Application of Fruquintinib for Previously Treated Metastatic Colorectal Cancer Validated by the European Medicines Agency
— Application Includes Data from Phase 3 FRESCO-2 and FRESCO Clinical Trials, which Demonstrated Superiority of Fruquintinib Plus Best Supportive Care (BSC)...
- 535Wire Stories
CSC Acquires Eddystone Financial Services, Expanding Loan Agency Offering in Australasia
WILMINGTON, Del.–(BUSINESS WIRE)–CSC, a leading provider of business, legal, tax, and digital brand services, announced today the acquisition of Eddystone Financial Services,...
- 491Wire Stories
Wipro Opens New 5G Def-i Innovation Center in Austin, Texas
Wipro’s first testing facility in the U.S., the Center will offer clients advanced 5G testing capabilities as well as mission-critical support AUSTIN,...
